Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intensive vs Conventional Insulin Therapy in Hyperglycemic COVID-19 Patients
NCT05441631Phase 1Completed
- Sponsor
- Benha University
- Start
- Apr 2020
- Primary completion
- Jul 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of human insulin in hyperglycemia and diabetes mellitus (DM) (2 arms), sponsored by Benha University. Primary endpoint: Patients' Survival at 12 months. Started Apr 2020; status: completed.
02
Drugs
human insulin
03
Conditions
hyperglycemiadiabetes mellitus (DM)
Beyond the preview
Go deeper on NCT05441631.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05441631.